News

Newsletter

Updates regarding public hearing about guidelines for the Examination of Patent Applications in the Biotechnology field

As informed on our Newsletter #03, on February 2019, the BRPTO started public hearing proceedings regarding the revised Guidelines for the Examination of Patent Applications in the Biotechnology Field. Now, on June 06, 2020, the BRPTO published the final revised version, which incorporated some of the suggestions submitted during the public hearings. The revised version comprises mainly few minor textual corrections and changes to make the text clearer.
 
For further information, click below to access our full newsletter.
Back

Last related news

September 6, 2022

Brazilian National Health Surveillance Agency authorizes exceptional drug and vaccine use against Monkeypox by the Ministry of Health

The Ministry of Health (MH) sent Brazilian National Health Surveillance Agency (Anvisa) a request for exemption from the sanitary registration, on an Brazilian National Health Surveillance Agency authorizes exceptional drug and vaccine use against Monkeypox by the Ministry of Health

Ler notícia

August 16, 2022

Brazilian National Health Surveillance Agency (ANVISA) decides to ban Carbendazim

On August 8th, 2022, during the 12th Extraordinary Public Meeting of DICOL, ANVISA’s Collegiate Board of Directors announced the completion of the toxicological Brazilian National Health Surveillance Agency (ANVISA) decides to ban Carbendazim

Ler notícia

July 19, 2022

Carbendazim toxicological revaluation about to be completed by ANVISA

In December 2019, ANVISA started the process of toxicological revaluation of the Active Ingredient (AI) Carbendazim, as signs of toxicity were identified Carbendazim toxicological revaluation about to be completed by ANVISA

Ler notícia